Today: 27 June 2026
Anthropic’s $900 Billion Fundraising Draws Attention to IPO Timeline
17 May 2026
2 mins read

Anthropic’s $900 Billion Fundraising Draws Attention to IPO Timeline

San Francisco, May 17, 2026, 03:31 (PDT)

Anthropic is back in the funding spotlight after the Financial Times said the Claude developer lined up a $30 billion round valuing the company near $900 billion. That number, if the deal goes through, would be almost three times Anthropic’s last confirmed valuation and put it among the biggest private tech financings ever.

The timing is key since there’s no public market for trading right now. U.S. exchanges don’t open on Sunday, and the NYSE trades its main session weekdays from 9:30 a.m. to 4 p.m. ET. That means investors can only size up Anthropic on private deals and IPO talk, not a share price. An initial public offering, or IPO, is when a company first sells its shares to public investors.

The reported price brings Anthropic closer to OpenAI, its main rival. OpenAI said on March 31 it raised $122 billion in committed capital and now has a post-money valuation of $852 billion, which is its value after adding new cash.

Anthropic kicked off last week’s run with a Bloomberg story saying it’s in early talks for at least $30 billion in new funds at a pre-money valuation over $900 billion, not counting the potential new money. Bloomberg said the deal isn’t done, and there’s no term sheet yet.

Greenoaks Capital, Sequoia Capital, Dragoneer and Altimeter Capital are leading the funding round for Anthropic, The Wall Street Journal reported. The paper said the round could top the $30 billion target as the company raises cash before a possible IPO. Anthropic is forecasting a $50 billion revenue run-rate by mid-2026, up from $9 billion at the end of 2025, according to the Journal. Run-rate revenue uses current sales to estimate a full year’s total, but it’s not the same as audited annual revenue.

The fundraising effort isn’t only for bumping up Anthropic’s valuation. Reuters said earlier this month Anthropic was considering raising tens of billions of dollars this summer to boost spending on computing power, which is expensive but needed for developing and running new AI models.

Anthropic last reported numbers in February, announcing $30 billion in Series G funding led by GIC and Coatue. That round gave the company a $380 billion post-money valuation. CFO Krishna Rao said at the time customers were saying “Claude is increasingly becoming critical” to business operations, and pointed to customer demand driving the new funding. Anthropic

Anthropic last week tried to show its tech can go beyond chatbots. The company and the Gates Foundation said they plan to put $200 million over four years into AI for health and education. Anthropic will give technical help and Claude credits, while the foundation handles grants and program design. “Core to who we are as a company,” said Elizabeth Kelly, who leads Anthropic’s beneficial deployments team. Reuters

Anthropic is getting stricter on stock sales before any IPO. The company’s help center, updated this week, said any stock sale that isn’t okayed by its board is void. Anthropic also said it does not allow SPVs—special purpose vehicles built to hold investments—to buy its shares, and warned that offers of indirect access may be invalid or scams.

But it isn’t a straight line. AI valuations are tied to steady revenue gains, chip and power supply, and whether public investors stay interested in companies burning through big sums of cash. Reuters Breakingviews said in March that Big Tech was set to spend about $650 billion this year, mostly on AI data centers, pointing to Morgan Stanley’s call for $2.9 trillion in global data-center investment between 2025 and 2028.

Investors are watching to see if this week brings a signed deal after earlier reports of talks and agreed terms, and if the round holds at $30 billion or goes higher. Market focus is also on whether Anthropic will name any backers, say more about IPO timing, or keep details under wraps.

Anthropic has gone from a fast-growing AI lab to a private-market benchmark, last week’s read shows. The question now is whether investors will agree to terms that let public buyers in with enough upside when the IPO drops.

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Stock Market Today

  • Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted
    June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified by the Fast Growing Stocks With High Insider Ownership screener, highlighting firms with aligned management-shareholder interests amid mixed inflation and cautious central bank policies.

Latest articles

Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

27 June 2026
Snowflake Inc (NYSE:SNOW) surged 9.65% to $248.96 on Friday with trading volume five times the weekly average, driven by FTSE Russell’s U.S. index reconstitution, turning a negative week into a 7.2% gain since June 18, as investors await whether the stock can hold above its previous $225.95–$230.41 range when index-driven liquidity fades next week.
GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Hyliion Stock Surges Almost 90% This Week; Monday Trading Could Set Next Move
Previous Story

Hyliion Stock Surges Almost 90% This Week; Monday Trading Could Set Next Move

Stripe’s secondary share price brings focus back to its paused IPO
Next Story

Stripe’s secondary share price brings focus back to its paused IPO

Go toTop